[喉白斑病的低温等离子消融治疗]

[Coblation treatment for larynx leukoplakia].

作者信息

Zhang N N, Zhang Q F, She C P

机构信息

Department of Otolaryngology, Dalian Municipal Central Hospital, Dalian Medical College, Dalian, 116033, China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 May 5;30(9):742-744. doi: 10.13201/j.issn.1001-1781.2016.09.018.

DOI:10.13201/j.issn.1001-1781.2016.09.018

PMID:29771027

Abstract

To evaluate the effect and feasibility of coblation treatment for larynx leukoplakia. One hundred and thirty-one cases with coblation treatment larynx leukoplakia were retrospectively analyzed from Jan 2009 to Dec 2013. One hundred and thirty one patients were treated with coblation, and follow-ups ranged 1 year to 6 years after surgry .Cure rate was 91.6%（120/131）after single surgry,and the recurrent rate was 8.4%（11/131）.Coblation treatment was an ideal method for larynx leukoplakia with less bleeding and less damage.

摘要

评估低温等离子消融术治疗喉白斑的疗效及可行性。回顾性分析2009年1月至2013年12月期间采用低温等离子消融术治疗喉白斑的131例患者。131例患者接受了低温等离子消融术治疗，术后随访1至6年。单次手术后治愈率为91.6%（120/131），复发率为8.4%（11/131）。低温等离子消融术是治疗喉白斑的理想方法，具有出血少、损伤小的特点。